Rocket Pharmaceuticals, Inc. (RCKT): Price and Financial Metrics
GET POWR RATINGS... FREE!
RCKT Stock Price Chart Interactive Chart >
RCKT Price/Volume Stats
| Current price | $22.50 | 52-week high | $23.48 |
| Prev. close | $21.99 | 52-week low | $7.57 |
| Day low | $22.50 | Volume | 3,144 |
| Day high | $22.50 | Avg. volume | 754,461 |
| 50-day MA | $20.10 | Dividend yield | N/A |
| 200-day MA | $15.98 | Market Cap | 1.70B |
Rocket Pharmaceuticals, Inc. (RCKT) Company Bio
Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.
Latest RCKT News From Around the Web
Below are the latest news stories about ROCKET PHARMACEUTICALS INC that investors may wish to consider to help them evaluate RCKT as an investment opportunity.
Rocket Pharmaceuticals (RCKT) Could Find a Support Soon, Here's Why You Should Buy the Stock NowRocket Pharmaceuticals (RCKT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. |
Wall Street Analysts Think Rocket Pharmaceuticals (RCKT) Could Surge 163.35%: Read This Before Placing a BetThe mean of analysts' price targets for Rocket Pharmaceuticals (RCKT) points to a 163.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. |
Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Fell -9.26% From Highs, What Does The Future Hold?Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)’s traded shares stood at 1.03 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $21.49, to imply an increase of 4.98% or $1.02 in intraday trading. The RCKT share’s 52-week high remains $23.48, putting it -9.26% down since that … Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Fell -9.26% From Highs, What Does The Future Hold? Read More » |
A stock that deserves closer examination: Rocket Pharmaceuticals Inc. (RCKT)The share price of Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) fell to $18.80 per share on Monday from $19.49. While Rocket Pharmaceuticals Inc. has underperformed by -3.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RCKT fell by -10.05%, with highs and lows ranging from $23.48 to $7.57, […] |
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon DiseaseRocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic th |
RCKT Price Returns
| 1-mo | 17.43% |
| 3-mo | 32.28% |
| 6-mo | 44.60% |
| 1-year | 35.95% |
| 3-year | 7.50% |
| 5-year | 25.42% |
| YTD | 14.97% |
| 2022 | -10.35% |
| 2021 | -60.19% |
| 2020 | 140.95% |
| 2019 | 53.58% |
| 2018 | 41.95% |
Loading social stream, please wait...